Hismanal Articles

Domestic vs JV drug prices in China differ

20 August 2007

Argentina bans terfenadine and astemizole

8 September 2003

Sepracor slumps as US FDA turns down antihistamine product Soltara

18 March 2002

Sepracor shares drop as new GERD agent trials are suspended by partner J&J

24 April 2001

New world market forecasts from DR

6 April 2001

Drugs withdrawn in the USA had greater health risk for women, says GAO study

12 February 2001

The growing importance of cytochromes - by Mark Greener

8 May 2000

GW, S-P push steroids for allergic rhinitis

7 July 1999

Hismanal withdrawn in face of competition

24 June 1999

J&J withdraws from norastemizole collaboration with Sepracor

19 May 1999

FDA/Consumers Drug Interactions Campaign

27 November 1998

Expanded Warnings For J&J's Hismanal

11 February 1998

French Reimbursable Delistings

18 December 1997

Tokyo Stock Comment

11 September 1997

Sepracor's Norastemizole "Effective" In Phase II

31 July 1997

CSM Curbs Terfenadine Use In UK

5 May 1997

First Approval Of Nelfinavir: Pediatric Indications Cleared

19 March 1997

Positive Verdict On Roche's Posicor From FDA Panel

10 March 1997

USA Approves Sporanox Pulse Dosing

23 December 1996

UK Plans To Add 60 Products to NHS Blacklist

2 December 1996

WFPMM Hears Self-Medication Warning

18 November 1996

Synthelabo Pipeline Supports "Seven Key Product" Strategy

21 October 1996

Accolate Cleared In USA For Asthma; 1st In Class

7 October 1996

Asthma Market growth To 2005

22 January 1996

Schering-Plough's Claritin: USA approval

9 October 1995

Disease ManagementThe Way Forward

15 May 1995

Hismanal Approval

20 February 1995

Japanese Year End Approvals

9 January 1995

Solvay Gains Luvox Approval From FDA

19 December 1994

ANTIHISTAMINE SAFETY QUESTIONED?

30 May 1994

MARKET WARMS TO COUGH & COLD SEASON IN USA

1 November 1993

NICOTINE PATCH COs SUFFER DECLINE IN US SALES

2 August 1993

DELISTING AND OTC SALES IN DENMARK

26 July 1993

PENDING APPLICATIONS IN US CONTINUE TO DWINDLE

19 July 1993

JANSSEN TO EXPAND IN CHINA

31 May 1993

EARNINGS GROWTH EXPANSION SEEN FOR UCB

31 May 1993

SEMPREX-D BACKED FOR HAYFEVER

17 May 1993

STRONG GROWTH BY US PHARMA COs IN 1st QTR

10 May 1993

EIRE POM TO P SWITCH

15 March 1993

SCHERING-PLOUGH'S CLARITYN GOES OTC

1 February 1993

SWITCHING POM TO OTC IN THE UK

14 December 1992

RX-TO-OTC SWITCHING FOR SUCCESS

2 November 1992

CANADA TOUGHENS ANTIHISTAMINES STANCE

3 August 1992

EUROPEAN ASTHMA TREATMENT MARKET

6 April 1992

EUROPEAN ASTHMA TREATMENT MARKET

6 April 1992

NORTH AMERICA'S OTC COUGH COLD MARKET

9 March 1992

Showing 1-46 of 46 articles

Go to beginningPrevious
  • 1
NextGo to end